Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-05-2019 | Magnetic Resonance Imaging | Head & Neck

The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas

Authors: Avi Khafif, Muhamed Masalha, Roee Landsberg, Liran Domachevsky, Hanna Bernstine, David Groshar, Ofer Azoulay, Yehudit Lockman

Published in: European Archives of Oto-Rhino-Laryngology | Issue 5/2019

Abstract

Purpose

Preoperative localization of a parathyroid adenoma is usually obtained by the combination of ultrasound and scintigraphy with technetium-99m methoxyisobutylisonitrile. We evaluated the role of F18-fluorocholine in neck positron emission tomography/magnetic resonance imaging as a novel tool for localizing parathyroid adenomas.

Methods

Patients with primary hyperparathyroidism were recruited from February 2016 to August 2017 and F18-fluorocholine positron emission tomography/magnetic resonance imaging was performed to localize the parathyroid adenoma prior to surgery. We compared sensitivity and accuracy of this modality with ultrasound and technetium-99m methoxyisobutylisonitrile scintigraphy using the verified location of the diseased parathyroid as found in surgery.

Results

Nineteen patients were included in our study (15 women and 4 men, mean age 60.5 ± 9.8 years). Positron emission tomography/magnetic resonance imaging precisely localized the pathologic parathyroid gland in 16/19 cases (84.2%) and predicted the diseased side in 19/19 cases (100%). Ultrasound and technetium 99 m methoxyisobutylisonitrile sestamibi scintigraphy predicted the location of the parathyroid adenoma in 16/19 (84.2%) and 14/19 (74%), respectively. In 3/19 patients, positron emission tomography/magnetic resonance imaging localized the parathyroid adenoma where as other modalities failed. Positron emission tomography/magnetic resonance imaging was more accurate when compared to each modality separately (p < 0.001, p = 0.017), however, when comparing the three modalities all together no differences were found (p = 0.506).

Conclusions

Localizing parathyroid adenomas with F18-fluorocholine positron emission tomography/magnetic resonance imaging may be a promising secondary imaging modality.

Brown SJ, Lee JC, Christie J, Maher R, Sidhu SB, Sywak MS, Delbridge LW (2015) 4DCT for parathyroid localization. ANZ J Surg 85:483–487. https://doi.org/10.1111/ans.12571 CrossRefPubMed

Suh YJ, Choi JY, Kim SJ, Chun IK, Yun TJ, Lee KE, Kim JH, Cheon GJ, Youn YK (2015) Comparison of 4D CT, ultrasonography, and ^99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism. Otolaryngol Head Neck Surg 152:438–443. https://doi.org/10.1177/0194599814562195 CrossRef

Kunstman JW, Kirsch JD, Mahajan A, Udelsman R (2013) Clinical review: parathyroid localization and implications for clinical management. J Clin Endocrinol Metab 98:902–912. https://doi.org/10.1210/jc.2012-3168 CrossRefPubMed

Kelly HR, Hamberg LM, Hunter GJ (2014) 4D–CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism: accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naïve and re-exploration patients. AJNR Am J Neuroradiol 35:176–181. https://doi.org/10.3174/ajnr.A3615 CrossRefPubMed

Rameau A, Eng S, Vu J, Saket R, Jun P, Friduss M (2017) Four-dimensional computed tomography scan utility in parathyroidectomy for primary hyperparathyroidism with low baseline intact parathyroid hormone. Laryngoscope 127:1476–1482. https://doi.org/10.1002/lary.26201 CrossRefPubMed

Kluijfhout WP, Pasternak JD, Drake FT et al (2016) Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg 401:925–935CrossRefPubMedPubMedCentral

Yuan L, Liu J, Kan Y, Yang J, Wang X (2017) The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis. Acta Radiol 58(5):558–564. https://doi.org/10.1177/0284185116661878 CrossRefPubMed

Noltes ME, Coester AM, Van der Horst-Schrivers ANA et al (2017) Localization of parathyroid adenomas using ¹¹C-methionine pet after prior inconclusive imaging. Langenbecks Arch Surg 402:1109–1117. https://doi.org/10.1007/s00423-017-1549-x CrossRefPubMedPubMedCentral

Weber T, Gottstein M, Schwenzer S, Beer A, Luster M (2017) Is C-11 methionine PET/CT able to localise sestamibi-negative parathyroid adenomas? World J Surg 41:980–985. https://doi.org/10.1007/s00268-016-3795-4 CrossRefPubMed

10.

Kluijfhout WP, Vorselaars WM, van den Berk SA et al (2016) Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun 37:1246–1252CrossRef

11.

Kluijfhout WP, Vorselaars WM, Vriens MR, Borel Rinkes IH, Valk GD, de Keizer B (2015) Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT. Eur J Radiol 84:1745–1751. https://doi.org/10.1016/j.ejrad.2015.05.024 CrossRef

12.

Gatidis S, Bender B, Reimold M, Schäfer JF (2017) PET/MRI in children. Eur J Radiol 94:A64–A70. https://doi.org/10.1016/j.ejrad.2017.01.018 CrossRefPubMed

13.

Mittal BR, Singh S (2017) Hybrid PET/MR imaging for evaluation of recurrence in gliomas: standard of care or luxury? Neurol India 65:302–304. https://doi.org/10.4103/0028-3886.201846 CrossRefPubMed

14.

Domachevsky L, Leibovitzh H, Avni-Biron I et al (2017) Correlation of 18F-FDG PET/MRE metrics with inflammatory biomarkers in patients with Crohns disease. a pilot study. Contrast Media Mol Imaging 19:7167292. https://doi.org/10.1155/2017/7167292 CrossRef

15.

McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22:276–282CrossRef

16.

Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef

17.

Ryan S, Courtney D, Moriariu J, Timon C (2017) Surgical management of primary hyperparathyroidism. Eur Arch Otorhinolaryngol 274:4225–4232. https://doi.org/10.1007/s00405-017-4776-4 CrossRefPubMed

18.

Kluijfhout WP, Pasternak JD, Gosnell JE et al (2017) 18F fluorocholine PET/MR imaging in patients with primary hyperparathyroidism and inconclusive conventional imaging: a prospective pilot study. Radiology 284:460–467. https://doi.org/10.1148/radiol.2016160768 CrossRef

19.

Huber GF, Hüllner M, Schmid C et al (2018) Benefit of ¹⁸F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol 28:2700–2707. https://doi.org/10.1007/s00330-017-5190-4 CrossRef

20.

Soyder A, Ünübol M, Ömürlü İK et al (2015) Minimally invasive parathyroidectomy without using intraoperative parathyroid hormone monitoring or gamma probe. Ulus Cerrahi Derg 31:9–14. https://doi.org/10.5152/UCD.2014.2572 CrossRefPubMedPubMedCentral

21.

Patel KN, Caso R (2016) Intraoperative parathyroid hormone monitoring: optimal utilization. Surg Oncol Clin N Am 25:91–101. https://doi.org/10.1016/j.soc.2015.08.005 CrossRefPubMed

22.

Sakimura C, Minami S, Hayashida N et al (2013) Can the use of intraoperative intact parathyroid hormone monitoring be abandoned in patients with hyperparathyroidism? Am J Surg 206:574–577. https://doi.org/10.1016/j.amjsurg.2013.01.043 CrossRefPubMed

23.

Helbrow J, Owais A, Sidwell A, Frank L, Lucarotti M (2016) The use of intraoperative parathyroid hormone monitoring in minimally invasive parathyroid surgery. Ann R Coll Surg Engl 98:516–519. https://doi.org/10.1308/rcsann.2016.0201 CrossRefPubMedPubMedCentral

Title: The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas
Authors: Avi Khafif
Muhamed Masalha
Roee Landsberg
Liran Domachevsky
Hanna Bernstine
David Groshar
Ofer Azoulay
Yehudit Lockman
Publication date: 01-05-2019
Publisher: Springer Berlin Heidelberg
Keywords: Magnetic Resonance Imaging
Ultrasound
Magnetic Resonance Imaging
Ultrasound
Positron Emission Tomography
Published in: European Archives of Oto-Rhino-Laryngology / Issue 5/2019
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-019-05301-2

ACC 2024 Congress

Springer Medicine

The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2019

Otosclerosis: anatomical distribution of otosclerotic loci analyzed by high-resolution computed tomography

The effects of endoscopic sinus surgery on pulmonary function in chronic rhinosinusitis patients with asthma: a systematic review and meta-analysis

Robotic cochlear implantation: feasibility of a multiport approach in an ex vivo model

Does procalcitonin have a role in the pathogenesis of nasal polyp?

Long-term health-related quality of life after mandibular resection and reconstruction

Acoustic neuroma quality of life: are we missing the point?